Clinical Trial Update: Palbociclib in Patients With Metastatic Castration-Resistant Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on palbociclib for metastatic castration-resistant prostate cancer; the study is currently active and not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Palbociclib (palbociclib)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Prostate Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING